- Home
- VIR vs PLAY Comparison
VIR vs PLAY Comparison
Compare VIR & PLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIR
- PLAY
- Stock Information
- Founded
- VIR 2016
- PLAY 1982
- Country
- VIR United States
- PLAY United States
- Employees
- VIR N/A
- PLAY N/A
- Industry
- VIR Biotechnology: Pharmaceutical Preparations
- PLAY Restaurants
- Sector
- VIR Health Care
- PLAY Consumer Discretionary
- Exchange
- VIR Nasdaq
- PLAY Nasdaq
- Market Cap
- VIR 859.9M
- PLAY 887.6M
- IPO Year
- VIR 2019
- PLAY 1995
- Fundamental
- Price
- VIR $5.65
- PLAY $14.24
- Analyst Decision
- VIR Strong Buy
- PLAY Hold
- Analyst Count
- VIR 11
- PLAY 8
- Target Price
- VIR $25.73
- PLAY $27.43
- AVG Volume (30 Days)
- VIR 1.5M
- PLAY 1.5M
- Earning Date
- VIR 11-05-2025
- PLAY 12-09-2025
- Dividend Yield
- VIR N/A
- PLAY N/A
- EPS Growth
- VIR N/A
- PLAY N/A
- EPS
- VIR N/A
- PLAY 0.26
- Revenue
- VIR $16,860,000.00
- PLAY $2,112,500,000.00
- Revenue This Year
- VIR N/A
- PLAY $2.83
- Revenue Next Year
- VIR $15.25
- PLAY $5.65
- P/E Ratio
- VIR N/A
- PLAY $54.74
- Revenue Growth
- VIR N/A
- PLAY N/A
- 52 Week Low
- VIR $4.16
- PLAY $13.12
- 52 Week High
- VIR $14.45
- PLAY $41.63
- Technical
- Relative Strength Index (RSI)
- VIR 50.14
- PLAY 36.84
- Support Level
- VIR $4.82
- PLAY $13.13
- Resistance Level
- VIR $5.84
- PLAY $15.55
- Average True Range (ATR)
- VIR 0.37
- PLAY 0.83
- MACD
- VIR -0.03
- PLAY 0.11
- Stochastic Oscillator
- VIR 47.70
- PLAY 24.22
About VIR Vir Biotechnology Inc.
Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.
About PLAY Dave & Buster's Entertainment Inc.
Dave & Buster's Entertainment Inc owns and operates nearly a hundred entertainment and dining establishments in the United States where customers can eat, drink, play games, and watch televised sports. Each store offers a full menu of entries and appetizers, a complete selection of alcoholic and non-alcoholic beverages, and an extensive assortment of entertainment attractions centered around playing games and watching live sports and other televised events. It derives maximum revenue from Entertainment.